Sarepta Therapeutics Inc (SRPT)

Return on equity (ROE)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	235,239	121,845	47,297	16,897	-535,977	-690,876	-907,677	-1,115,218	-703,488	-716,225	-506,631	-356,555	-418,780	-486,116	-634,471	-703,886	-554,128	-600,514	-530,341	-655,924
Total stockholders’ equity	US$ in thousands	1,527,740	1,221,070	1,077,070	961,192	859,337	764,357	741,411	712,749	384,950	430,840	726,457	856,886	928,009	469,528	485,108	535,445	761,759	892,047	1,042,870	1,144,830
ROE		15.40%	9.98%	4.39%	1.76%	-62.37%	-90.39%	-122.43%	-156.47%	-182.75%	-166.24%	-69.74%	-41.61%	-45.13%	-103.53%	-130.79%	-131.46%	-72.74%	-67.32%	-50.85%	-57.29%

December 31, 2024 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $235,239K ÷ $1,527,740K
= 15.40%

Sarepta Therapeutics Inc's return on equity (ROE) has shown significant fluctuation over the analyzed period. The ROE started with negative values, indicating that the company was generating losses in relation to its equity.

The ROE deteriorated further in the first half of 2021, reaching its lowest point with values exceeding negative 130%. However, from the end of 2021 onwards, there was a notable improvement in ROE performance, turning positive by the first quarter of 2024.

The positive ROE values from then on suggest that Sarepta Therapeutics Inc started generating profits in relation to its shareholders' equity, reflecting a better utilization of its assets to generate earnings. The increasing trend in ROE from 2022 onwards indicates a positive turnaround in the company's profitability and efficiency in generating returns for its shareholders.